Opentrons

Opentrons

Affordable laboratory automation solutions provider

About Opentrons

Simplify's Rating
Why Opentrons is rated
A-
Rated B on Competitive Edge
Rated A on Growth Potential
Rated A on Rating Differentiation

Industries

Biotechnology

Healthcare

Company Size

201-500

Company Stage

Series C

Total Funding

$230.6M

Headquarters

New York City, New York

Founded

2014

Overview

Opentrons provides affordable and user-friendly laboratory automation solutions, primarily targeting the biotechnology and life sciences sectors. Their main product, the OT-2, is a liquid handling robot that automates repetitive tasks like pipetting, which involves transferring liquids between containers. Opentrons sells these robotic systems along with complementary software and consumables, generating revenue through direct hardware sales and subscriptions for software. What sets Opentrons apart from competitors is its focus on making automation accessible to smaller labs and institutions that may not afford traditional, expensive systems. Their products are designed for easy setup and use, lowering the barriers for labs to adopt automation technology. The goal of Opentrons is to transform laboratory automation by providing cost-effective and user-friendly robotic solutions for a diverse range of clients.

YC Company
Simplify Jobs

Simplify's Take

What believers are saying

  • Growing demand for no-code solutions boosts Opentrons' market potential.
  • Educational initiatives like Opentrons for Education address biotech skill gaps.
  • Strategic partnerships enhance Opentrons' lab automation capabilities.

What critics are saying

  • Increased competition may erode Opentrons' market share.
  • Rapid tech advancements require significant R&D investment to stay competitive.
  • Supply chain vulnerabilities could impact Opentrons' production capabilities.

What makes Opentrons unique

  • Opentrons offers affordable lab automation solutions for smaller labs and institutions.
  • Their OT-2 robot is user-friendly, reducing barriers to lab automation adoption.
  • Opentrons' no-code Flex Prep robot simplifies pipetting tasks for non-programmers.

Help us improve and share your feedback! Did you find this helpful?

Funding

Total Funding

$230.6M

Above

Industry Average

Funded Over

3 Rounds

Notable Investors:
Series C funding is usually for startups that are doing well and are looking for more money to fuel major growth, such as acquiring other companies, expanding into global markets, or launching new product lines. Investors typically include larger venture capital firms and private equity.
Series C Funding Comparison
Above Average

Industry standards

$50M
$50M
Medium
$62M
SeatGeek
$100M
Oura
$200M
Opentrons

Growth & Insights and Company News

Headcount

6 month growth

0%

1 year growth

0%

2 year growth

1%
Business Wire
Mar 13th, 2025
Copia Scientific Announces Strategic Distribution Agreement with Opentrons

Copia Scientific announces strategic distribution agreement with Opentrons.

The Robot Report
Sep 15th, 2024
Opentrons Releases No-Code Robot For Pipetting Tasks

Opentrons releases no-code robot for pipetting tasks. By The Robot Report Staff | September 15, 2024Listen to this articleOpentrons’ Flex Prep robot can perform pipetting tasks such as sample reformatting, plate prep, dilutions, concentration normalization, cherry-picking, and more. | Source: Opentrons. Opentrons Labworks, Inc. launched its Flex Prep robot this week. It’s paired with new no-code software that allows users to set up pipetting tasks and execute that workflow all through a touchscreen

Business Wire
Sep 12th, 2024
Opentrons introduces Flex Prep: A no-code robot offering the simplicity of a pipette with the versatility of a liquid handler

Opentrons introduces Flex Prep: A no-code robot offering the simplicity of a pipette with the versatility of a liquid handler.

Business Wire
Mar 12th, 2024
Opentrons Announces New Robotics Education Initiative Demonstrating Commitment To Laboratory Automation For Students

BROOKLYN, N.Y.--(BUSINESS WIRE)--Opentrons Labworks, Inc., a leader in lab automation and makers of accessible lab robotics, today announced the launch of Opentrons® for Education, an exclusive offering for educators to bring lab automation to the classroom. Opentrons is building a first-of-its-kind ecosystem for teaching with automation, which includes education pricing and support, along with access to a community of educators already teaching with Opentrons. Our goal is to make lab automation a universal skill. Bringing lab automation to the classroom gives students a competitive advantage for their careers by addressing the growing skill gap faced by biotech companies. Opentrons for Education is the key to unlocking a new era of hands-on, innovative learning in the realm of laboratory sciences. "The life sciences industry has been slow to adopt lab automation due to the precision required to manipulate precious samples and reagents at milliliter and microliter volumes, and the lack of skilled personnel to introduce automated workflows into labs

Business Wire
Feb 22nd, 2024
Opentrons Announces Medical Robotics Expert Gregory Cole As Chief Innovation Officer To Accelerate Ai-Driven Robo-Lab Partnerships And Innovations

BROOKLYN, N.Y.--(BUSINESS WIRE)--Opentrons Labworks, Inc., a leader in lab automation and makers of accessible lab robotics, today announced the appointment of Gregory Cole, PhD as Chief Innovation Officer. With over a decade of medical robotics, IP strategy, and product commercialization expertise, Dr. Cole will be responsible for establishing commercial and academic partnerships with leading research institutions and biopharma companies and creating novel product solutions for the company’s Opentrons Flex, the first liquid-handling robot designed to be compatible with “design-of-experiment” programs, including AI-driven agents utilizing large language models (LLMs). "Greg's remarkable experience underscores his proficiency in steering robotic technologies towards successful commercialization," said Jonathan Brennan-Badal, CEO of Opentrons. "With a proven history of advancing medical robotics and fostering corporate partnerships, he will play a pivotal role in driving the continued global reach of Opentrons Flex and delivering innovative automated solutions to life science researchers. We welcome Greg to the Opentrons family."

There are no jobs for Opentrons right now.

Find jobs on Simplify and start your career today

💡
Don't see your dream role? Check out thousands of other roles on Simplify. Browse all jobs →